Approximately 9% of people with MDS present with a missense mutation (S34F) in the splicing factor U2AF1, which, in transgenic mice, showed an ability to alter splicing in hematopoietic progenitor cells and to cause defective hematopoiesis [157,158,159]. The gene discussed is U2AF1; the disease is myelodysplastic syndrome.